Validant Acquires DataRevive to Enhance Regulatory Support for Biopharma Product Approvals

VCBeat (WeChat ID: vcbeat) has learned that on November 1, 2019, Validant, a regulatory consulting firm in the biopharmaceutical sector, completed its acquisition of DataRevive. No financial terms of the transaction were disclosed.

Validant, founded in 2005 and headquartered in California, USA, is an internationally leading quality compliance and regulatory consulting firm. By combining industry expertise with innovation, the company provides strategic guidance on regulatory approval pathways to biotechnology and pharmaceutical companies worldwide, delivering tailored solutions for organizations at the forefront of healthcare.

Validant’s team comprises outstanding engineers, scientists, clinicians, and experts with extensive experience in collaborating with the FDA, health authorities, and other regulatory agencies.

DataRevive, founded by CEO Audrey Jia in 2016, is a leading regulatory consulting firm in the biopharmaceutical and life sciences sectors. Its team comprises former FDA officials and biopharmaceutical industry professionals, providing high-quality advice from both healthcare industry and regulatory perspectives to help clients successfully navigate the product approval process.

DataRevive can represent clients in face-to-face meetings with the FDA (such as PIND meetings and pre-BLA meetings), conduct gap assessments and reviews for clients, and assist clients with IND filings and subsequent IND maintenance.

Validant’s acquisition of DataRevive is part of its international growth strategy. The combination of DataRevive and Validant will strengthen both parties’ capabilities and expand the merged group’s range of consulting services in the life sciences sector, enabling better support for customers throughout the entire product development lifecycle.

As part of this acquisition, Validant will establish a new office in Washington, D.C., complementing its existing presence in San Francisco, the Research Triangle Park in North Carolina, and Cork, Ireland. Leveraging DataRevive’s extensive network of international clients, Validant will also expand its operations into key emerging markets.

Brian Burns, CEO of Validant, stated, “The DataRevive team has brought extensive new expertise into our business, enhancing Validant’s team capabilities. This collaboration will position us more competitively within the industry, enabling us to better meet the product filing needs of both existing and future clients.”

Audrey Jia, CEO of DataRevive, stated, “By joining forces with Validant, we will gain new commercial channels to serve a broader base of biopharmaceutical clients. This collaboration will enhance our world-class regulatory services, enabling our clients to accelerate product development and commercialization. We look forward to leveraging Validant’s network and best-in-class operating model to expand our customer base.”

(Compiled by Jiang Ying)